At the heart of the Belgian Biotech, DICE is a Contract Research Organization with 30+ years of experience in the conduct of clinical trials, having assisted in the execution of 300+ Phase I to IV studies across a range of therapeutic areas and medical technologies.

We're known for high-quality results; 80% of our business is recurring, with relationships lasting up to 25 years. Our client base spans Europe, the US, and Asia.

DICE specializes in start-ups and scale-ups, tailoring services for them. We collaborate with clients to define project goals and execute efficiently, meeting regulatory guidelines.

We also have significant experience with preparation and defense at EMA and FDA, helping our clients access the EU and US market.

DICE has expertise in various therapeutic areas including oncology, neurology, ophthalmology, hematology, orphan diseases, endocrinology, gastroenterology, pneumology, urology, autoimmune disease, diabetes, metabolic disorders, and Pediatric diseases.